3)

Част 3 се изменя, както следва: а) заглавието на част 3 се заменя със следното: „3. ЧАСТ 3:ТАБЛИЦА НА ХАРМОНИЗИРАНИ КЛАСИФИКАЦИЯ И ЕТИКЕТИРАНЕ“; б) уводните алинеи се заличават; в) заглавието на таблица 3.1 се заменя със следното: „Таблица 3 Списък на хармонизирани класификация и етикетиране на опасни вещества“; г) таблица 3 се изменя, както следва: i) заглавието на предпоследната колона се заменя със следното: „Специфични пределни концентрации, М-коефициенти и ATE“; ii) вписванията, съответстващи на индекс № 006-046-00-8, 604-057-00-8, 605-023-00-5, 606-041-00-6, 607-123-00-4, 608-055-00-8, 612-150-00-X, 613-318-00-5, 614-001-00-4, 615-013-00-2, 616-006-00-7, 616-094-00-7 и 650-032-00-X, се заменят със следните вписвания: Индекс № Международна химична идентификация ЕО № CAS № Класификация Етикетиране Специфични пределни концентрации, М- коефициенти и ATE Бележки Код(ове) на класа(овете) и категорията(иите) на опасност Код(ове) на предупреждението(ята) за опасност Кодове на пиктограмата(ите) и сигналната(ите) дума(и) Код(ове) на предупреждението(ята) за опасност Код(ове) на допълнителното(ите) предупреждение(я) за опасност „006-046-00-8 bendiocarb (ISO); 2,2-dimethyl-1,3-benzodioxol-4-yl N-methylcarbamate; 2,2-dimethyl-1,3-benzodioxol-4-yl methylcarbamate 245-216-8 22781-23-3 Acute Tox. 3 Acute Tox. 3 Acute Tox. 2 Aquatic Acute 1 Aquatic Chronic 1 H331 H311 H300 H400 H410 GHS06 GHS09 Dgr H331 H311 H300 H410 M = 10 M = 100“ „604-057-00-8 reaction mass of: isomers of 2-(2H-benzotriazol-2-yl)-4-methyl-(n)-dodecylphenol; isomers of 2-(2H-benzotriazol-2-yl)-4-methyl-(n)-tetracosylphenol; isomers of 2-(2H-benzotriazol-2-yl)-4-methyl-5,6-didodecyl-phenol. n = 5 or 6 401-680-5 — Aquatic Chronic 4 H413 H413“ „605-023-00-5 5-chloro-2-(4-chlorophenoxy)phenol; [DCPP] 429-290-0 3380-30-1 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 H318 H400 H410 GHS05 GHS09 Dgr H318 H410 M = 10 M = 10“ „606-041-00-6 2-methyl-1-(4-methylthiophenyl)-2-morpholinopropan-1-one 400-600-6 71868-10-5 Repr. 1B Acute Tox. 4 * Aquatic Chronic 2 H360FD H302 H411 GHS08 GHS07 GHS09 Dgr H360FD H302 H411“ „607-123-00-4 2,3-epoxypropyl methacrylate; glycidyl methacrylate 203-441-9 106-91-2 Carc. 1B Muta. 2 Repr. 1B Acute Tox. 3 Acute Tox. 4 STOT SE 3 STOT RE 1 Eye Dam. 1 Skin Corr. 1C Skin Sens. 1 H350 H341 H360F H311 H302 H335 H372 (дихателни пътища) (вдишване) H318 H314 H317 GHS08 GHS06 GHS05 Dgr H350 H341 H360F H311 H302 H335 H372 (дихателни пътища) (вдишване) H314 H317 D“ „608-055-00-8 fipronil (ISO); (±)-5-amino-1-(2,6-dichloro-α,α,α-trifluoro-para-tolyl)-4-trifluoromethylsulfinyl-pyrazole-3-carbonitrile 424-610-5 120068-37-3 Acute Tox. 3* Acute Tox. 3* Acute Tox. 3* STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 H301 H311 H331 H372* H400 H410 GHS06 GHS08 GHS09 Dgr H301 H311 H331 H372* H410 M = 1 000 M = 10 000 “ „612-150-00-X spiroxamine (ISO); 8-tert-butyl-1,4-dioxaspiro[4.5]decan-2-ylmethyl(ethyl)(propyl)amine — 118134-30-8 Repr. 2 Acute Tox. 4 Acute Tox. 4 Acute Tox. 4 STOT RE 2 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H361d H332 H312 H302 H373 (очи) H315 H317 H400 H410 GHS08 GHS07 GHS09 Wng H361d H332 H312 H302 H373 (очи) H315 H317 H410 M = 100 M = 100“ „613-318-00-5 fenpyrazamine (ISO); S-allyl 5-amino-2,3-dihydro-2-isopropyl-3-oxo-4-(o-tolyl)pyrazole-1-carbothioate; S-allyl 5-amino-2-isopropyl-4-(2-methylphenyl)-3-oxo-2,3-dihydropyrazole-1-carbothioate — 473798-59-3 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410 M = 10 M = 1“ „614-001-00-4 nicotine (ISO); 3-[(2S)-1-methylpyrrolidin-2-yl]pyridine 200-193-3 54-11-5 Acute Tox. 2 Acute Tox. 2 Acute Tox. 2 Aquatic Chronic 2 H330 H310 H300 H411 GHS06 GHS09 Dgr H330 H310 H300 H411 вдишване: ATE = 0.19 mg/L (прах или мъгла) кожна: ATE = 70 mg/kg орална: ATE (*1) = 5 mg/kg“ „615-013-00-2 cyanamide; carbamonitril 206-992-3 420-04-2 Carc. 2 Repr. 2 Acute Tox. 3 Acute Tox. 3 STOT RE 2 Skin Corr. 1 Skin Sens. 1 Eye Dam. 1 Aquatic Chronic 3 H351 H361fd H311 H301 H373 (щитовидна жлеза) H314 H317 H318 H412 GHS08 GHS06 GHS05 Dgr H351 H361fd H311 H301 H373 (щитовидна жлеза) H314 H317 H412“ „616-006-00-7 dichlofluanid (ISO); N-[(dichlorofluoromethyl)thio]-N′,N′-dimethyl-N-phenylsulfamide 214-118-7 1085-98-9 Acute Tox. 4 Eye Irrit. 2 Skin Sens. 1 Aquatic Acute 1 H332 H319 H317 H400 GHS07 GHS09 Wng H332 H319 H317 H400 M = 10“ „616-094-00-7 3,3′-dicyclohexyl-1,1′-methylenebis(4,1-phenylene)diurea 406-370-3 58890-25-8 Aquatic Chronic 4 H413 H413“ „650-032-00-X cyproconazole (ISO); (2RS,3RS;2RS,3SR)-2-(4-chlorophenyl)-3-cyclopropyl-1-(1H-1,2,4-triazol-1-yl)butan-2-ol — 94361-06-5 Repr. 1B Acute Tox. 3 STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 H360D H301 H373 (черен дроб) H400 H410 GHS08 GHS06 GHS09 Dgr H360D H301 H373 (черен дроб) H410 M = 10 M = 1“ iii) вмъкват се следните вписвания в съответствие с реда на вписванията, определен в таблица 3: Индекс № Международна химична идентификация ЕО № CAS № Класификация Етикетиране Специфични пределни концентрации, М-коефициенти и АТЕ Бележки Код(ове) на класа(овете) и категорията(иите) на опасност Код(ове) на предупреждението(ята) за опасност Кодове на пиктограмата(ите) и сигналната(ите) дума(и) Код(ове) на предупреждението(ята) за опасност Код(ове) на допълнителното(ите) предупреждение(я) за опасност „047-003-00-3 silver zinc zeolite (Zeolite, LTA framework type, surface-modified with silver and zinc ions) [This entry covers LTA (Linde Type A) framework type zeolite which has been surface-modified with both silver and zinc ions at contents Ag+ 0,5 %-6 %, Zn2 + 5 %-16 %, and potentially with phosphorus, NH4+, Mg2+ and/or Ca2+ each at level < 3 %] — 130328-20-0 Repr. 2 Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 H361d H315 H318 H400 H410 GHS08 GHS05 GHS09 Dgr H361d H315 H318 H410 M = 100 M = 100“ „048-012-00-5 cadmium carbonate 208-168-9 513-78-0 Carc. 1B Muta. 1B Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 H350 H340 H332 H312 H302 H372 (бъбреци, кости) H400 H410 GHS08 GHS07 GHS09 Dgr H350 H340 H332 H312 H302 H372 (бъбреци, кости) H410 A1“ „048-013-00-0 cadmium hydroxide; cadmium dihydroxide 244-168-5 21041-95-2 Carc. 1B Muta. 1B Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 H350 H340 H332 H312 H302 H372 (бъбреци, кости) H400 H410 GHS08 GHS07 GHS09 Dgr H350 H340 H332 H312 H302 H372 (бъбреци, кости) H410 A1“ „048-014-00-6 cadmium nitrate; cadmium dinitrate 233-710-6 10325-94-7 Carc. 1B Muta. 1B Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 H350 H340 H332 H312 H302 H372 (бъбреци, кости) H400 H410 GHS08 GHS07 GHS09 Dgr H350 H340 H332 H312 H302 H372 (бъбреци, кости) H410 Carc. 1B; H350: C ≥ 0,01 % A1“ „050-030-00-3 dibutyltin dilaurate; dibutyl[bis(dodecanoyloxy)]stannane 201-039-8 77-58-7 Muta. 2 Repr. 1B STOT RE 1 H341 H360FD H372 (имунна система) GHS08 Dgr H341 H360FD H372 (имунна система)“ „603-235-00-2 linalool; 3,7-dimethyl-1,6-octadien-3-ol; dl-linalool; [1] coriandrol; (S)-3,7-dimethyl-1,6-octadien-3-ol; d-linalool; [2] licareol; (R)-3,7-dimethyl-1,6-octadien-3-ol; l-linalool [3] 201-134-4 [1] 204-810-7 [2] 204-811-2 [3] 78-70-6 [1] 126-90-9 [2] 126-91-0 [3] Skin Sens. 1B H317 GHS07 Wng H317“ „604-093-00-4 clorofene; chlorophene; 2-benzyl-4-chlorophenol 204-385-8 120-32-1 Carc. 2 Repr. 2 Acute Tox. 4 Skin Irrit. 2 Skin Sens. 1 Eye Dam. 1 STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 H351 H361f H332 H315 H317 H318 H373 (бъбреци) H400 H410 GHS08 GHS05 GHS07 GHS09 Dgr H351 H361f H332 H315 H317 H318 H373 (бъбреци) H410 M = 1 M = 100“ „606-150-00-9 clethodim (ISO); (5RS)-2-{(1EZ)-1-[(2E)-3-chloroallyloxyimino]propyl}-5-[(2RS)-2-(ethylthio)propyl]-3-hydroxycyclohex-2-en-1-one — 99129-21-2 Acute Tox. 4 Skin Sens. 1 Aquatic Chronic 3 H302 H317 H412 GHS07 Wng H302 H317 H412 EUH066“ „606-151-00-4 anthraquinone 201-549-0 84-65-1 Carc. 1B H350 GHS08 Dgr H350“ „607-720-00-X nonadecafluorodecanoic acid; [1] ammonium nonadecafluorodecanoate; [2] sodium nonadecafluorodecanoate [3] 206-400-3 [1] 221-470-5 [2] [3] 335-76-2 [1] 3108-42-7 [2] 3830-45-3 [3] Carc. 2 Repr. 1B Lact. H351 H360Df H362 GHS08 Dgr H351 H360Df H362“ „607-721-00-5 N,N′-methylenedimorpholine; N,N′-methylenebismorpholine; [formaldehyde released from N,N′-methylenebismorpholine]; [MBM] 227-062-3 5625-90-1 Carc. 1B Muta. 2 Acute Tox. 4 Acute Tox. 4 Acute Tox. 4 STOT RE 2 Skin Corr. 1B Skin Sens. 1 Eye Dam.1 H350 H341 H332 H312 H302 H373 (стомашно-чревен тракт, дихателни пътища) H314 H317 H318 GHS08 GHS07 GHS05 Dgr H350 H341 H332 H312 H302 H373 (стомашно-чревен тракт, дихателни пътища) H314 H317 EUH071 8 9“ „607-722-00-0 2,3,5,6-tetrafluoro-4-(methoxymethyl)benzyl (Z)-(1R,3R)-3-(2-cyanoprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate; epsilon-momfluorothrin — 1065124-65-3 Acute Tox. 4 STOT SE 2 Aquatic Acute 1 Aquatic Chronic 1 H302 H371 (нервна система) H400 H410 GHS07 GHS08 GHS09 Wng H302 H371 (нервна система) H410 M = 100 M = 100“ „607-723-00-6 tefluthrin (ISO); 2,3,5,6-tetrafluoro-4-methylbenzyl (1RS,3RS)-3-[(Z)-2-chloro-3,3,3-trifluoroprop-1-enyl]-2,2-dimethylcyclopropanecarboxylate — 79538-32-2 Acute Tox. 1 Acute Tox. 2 Acute Tox. 2 Aquatic Acute 1 Aquatic Chronic 1 H330 H310 H300 H400 H410 GHS06 GHS09 Dgr H330 H310 H300 H410 M = 10 000 M = 10 000 “ „612-290-00-1 reaction products of paraformaldehyde and 2-hydroxypropylamine (ratio 3:2); [formaldehyde released from 3,3′-methylenebis[5-methyloxazolidine]; formaldehyde released from oxazolidin]; [MBO] — — Carc. 1B Muta. 2 Acute Tox. 4 Acute Tox. 3 Acute Tox. 4 STOT RE 2 Skin Corr. 1B Eye Dam. 1 Skin Sens. 1 A Aquatic Chronic 2 H350 H341 H332 H311 H302 H373 (стомашно-чревен тракт, дихателни пътища) H314 H318 H317 H411 GHS08 GHS06 GHS05 GHS09 Dgr H350 H341 H332 H311 H302 H373 (стомашно-чревен тракт, дихателни пътища) H314 H317 H411 EUH071 8 9“ „612-291-00-7 reaction products of paraformaldehyde with 2-hydroxypropylamine (ratio 1:1); [formaldehyde released from α,α,α-trimethyl-1,3,5-triazine-1,3,5(2H,4H,6H)-triethanol]; [HPT] — — Carc. 1B Muta. 2 Acute Tox. 4 Acute Tox. 4 STOT RE 2 Skin Corr. 1C Eye Dam. 1 Skin Sens. 1 A Aquatic Chronic 2 H350 H341 H332 H302 H373 (стомашно-чревен тракт, дихателни пътища) H314 H318 H317 H411 GHS08 GHS07 GHS05 GHS09 Dgr H350 H341 H332 H302 H373 (стомашно-чревен тракт, дихателни пътища) H314 H317 H411 EUH071 8 9“ „612-292-00-2 methylhydrazine 200-471-4 60-34-4 Carc. 1B H350 GHS08 Dgr H350“ „613-321-00-1 (RS)-4-[1-(2,3-dimethylphenyl)ethyl]-1H-imidazole; medetomidine — 86347-14-0 Acute Tox. 2 Acute Tox. 2 STOT SE 3 STOT SE 1 STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 H330 H300 H336 H370 (очи) H372 H400 H410 GHS06 GHS08 GHS09 Dgr H330 H300 H336 H370 (очи) H372 H410 M = 1 M = 100“ „613-322-00-7 triadimenol (ISO); (1RS,2RS;1RS,2SR)-1-(4-chlorophenoxy)-3,3-dimethyl-1-(1H-1,2,4-triazol-1-yl)butan-2-ol; α-tert-butyl-β-(4-chlorophenoxy)-1H-1,2,4-triazole-1-ethanol 259-537-6 55219-65-3 Repr. 1B Lact. Acute Tox. 4 Aquatic Chronic 2 H360 H362 H302 H411 GHS08 GHS07 GHS09 Dgr H360 H362 H302 H411“ „613-323-00-2 terbuthylazine (ISO); N-tert-butyl-6-chloro-N′-ethyl-1,3,5-triazine-2,4-diamine 227-637-9 5915-41-3 Acute Tox. 4 STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 H302 H373 H400 H410 GHS07 GHS08 GHS09 Wng H302 H373 H410 M = 10 M = 10“ „613-324-00-8 quinolin-8-ol; 8-hydroxyquinoline 205-711-1 148-24-3 Repr. 1B Acute Tox. 3 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H360D H301 H318 H317 H400 H410 GHS08 GHS06 GHS05 GHS09 Dgr H360D H301 H318 H317 H410 M = 1 M = 1“ „613-325-00-3 thiacloprid (ISO); (Z)-3-(6-chloro-3-pyridylmethyl)-1,3-thiazolidin-2-ylidenecyanamide; {(2Z)-3-[(6-chloropyridin-3-yl)methyl]-1,3-thiazolidin-2-ylidene}cyanamide — 111988-49-9 Carc. 2 Repr. 1B Acute Tox. 4 Acute Tox. 3 STOT SE 3 Aquatic Acute 1 Aquatic Chronic 1 H351 H360FD H332 H301 H336 H400 H410 GHS08 GHS06 GHS09 Dgr H351 H360FD H332 H301 H336 H410 M = 100 M = 100“ „616-221-00-6 hexaflumuron (ISO); 1-(3,5-dichloro-4-(1,1,2,2-tetrafluoroethoxy)phenyl)-3-(2,6-difluorobenzoyl)urea 401-400-1 86479-06-3 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410 M = 1 000 M = 10 000 “ „616-222-00-1 penthiopyrad (ISO); (RS)-N-[2-(1,3-dimethylbutyl)-3-thienyl]-1-methyl-3-(trifluoromethyl)pyrazole-4-carboxamide — 183675-82-3 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410 M = 1 M = 1“ „616-223-00-7 carbetamide (ISO); (R)-1-(ethylcarbamoyl)ethyl carbanilate; (2R)-1-(ethylamino)-1-oxopropan-2-yl phenylcarbamate 240-286-6 16118-49-3 Carc. 2 Repr. 1B Acute Tox. 4 Aquatic Chronic 2 H351 H360D H302 H411 GHS08 GHS07 GHS09 Dgr H351 H360D H302 H411“